多重化蛋白质和创造力路径 艾滋病毒病毒抑制妇女注意力/工作记忆的分析:可行性研究
Wei Li1, Leah H Rubin2, Yanxun Xu3,4
1School of Health Professions, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Diagnostics (Basel, Switzerland)
|October 29, 2025
概括
血蛋白生物标志物与艾滋病毒感染妇女 (WWH) 的认知功能有关. 像TNF RI和IL-6R这样的特定蛋白质对注意力和工作记忆产生了负面影响,这表明了潜在的网络关联.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生化学
背景情况:
- 血蛋白生物标志物与艾滋病毒感染者 (PWH) 的认知表现相关.
- 了解这些生物标志物对于WWH的认知健康至关重要.
- 之前的研究集中在单个生物标志物上,需要采用蛋白质组签名方法.
研究的目的:
- 调查血蛋白质组特征与艾滋病毒 (WWH) 病毒学上得到良好控制的妇女的注意力/工作记忆之间的联系.
- 为了确定特定的蛋白质生物标志物,与这种人群的认知功能相关.
- 探索涉及HIV相关认知变化的潜在生物途径.
主要方法:
- 来自妇女机构间艾滋病毒研究 (WIHS) 的77名WWH接受了神经心理测试和血液抽取.
- 使用多重复合方法分析了200个选择的血蛋白生物标志物.
- 随机森林分析确定了顶级生物标志物,而创造力路径分析 (IPA) 则促进了解释.
主要成果:
- 随机森林分析确定了与注意力/工作记忆相关的10个关键蛋白质生物标志物.
- 瘤坏死因子受体1 (TNF RI),TNF RII,互白素1受体1 (IL-1RI) 和IL-6R与认知表现有负相关性.
- IPA建议两个基因信号网络将这些生物标志物与注意力/工作记忆联系起来.
结论:
- 这项研究确定了与WWH中的注意力/工作记忆相关的特定血蛋白生物标志物.
- 这些发现提出了新的基因信号网络,涉及到WWH的认知功能.
- 这种方法强调了将蛋白质组数据与用于生物标志物发现的认知评估相结合的潜力.
相关概念视频
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...


